MedTrace Logo

Non-interventional Study to Evaluate the Ease of Reaching Individual Goals in Serum Phosphorus (Steering)

NCT01424787 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 324

Last updated 2015-03-06

No results posted yet for this study

Summary

The objective of this non-interventional study is to confirm that with standard OsvaRen® treatment it is possible to achieve in at least 60% of the patients the levels of phosphorus, total calcium, and iPTH seen in the CALMAG study also in the normal clinical practice.

Conditions

  • Hyperphosphataemia
  • ESRD

Sponsors & Collaborators

  • Siro Clinpharm Germany GmbH

    collaborator INDUSTRY

  • Fresenius Medical Care Deutschland GmbH

    lead INDUSTRY

Principal Investigators

  • Helmut Geiger, MD, Prof · University Hospital, Frankfurt, Germany

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2014-03-31
Completion
2014-03-31

Countries

  • Denmark
  • Germany
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01424787 on ClinicalTrials.gov